X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ALEMBIC LTD - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ALEMBIC LTD STERLING BIOTECH/
ALEMBIC LTD
 
P/E (TTM) x -0.4 53.4 - View Chart
P/BV x 0.0 2.2 0.7% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 STERLING BIOTECH   ALEMBIC LTD
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ALEMBIC LTD
Mar-18
STERLING BIOTECH/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1172 14.6%   
Low Rs334 10.0%   
Sales per share (Unadj.) Rs26.84.7 570.3%  
Earnings per share (Unadj.) Rs-15.06.1 -245.0%  
Cash flow per share (Unadj.) Rs-5.56.2 -87.5%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs54.940.7 135.0%  
Shares outstanding (eoy) m267.87267.03 100.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.311.3 2.3%   
Avg P/E ratio x-0.58.7 -5.4%  
P/CF ratio (eoy) x-1.38.5 -15.0%  
Price / Book Value ratio x0.11.3 9.7%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m1,86214,139 13.2%   
No. of employees `0001.4NA-   
Total wages/salary Rs m547207 263.6%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,1811,255 572.1%  
Other income Rs m43370 11.5%   
Total revenues Rs m7,2231,625 444.4%   
Gross profit Rs m947111 852.3%  
Depreciation Rs m2,54338 6,728.0%   
Interest Rs m4,3772 257,476.5%   
Profit before tax Rs m-5,931442 -1,342.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92424 -8,034.7%   
Profit after tax Rs m-4,0071,630 -245.8%  
Gross profit margin %13.28.9 149.0%  
Effective tax rate %32.45.4 598.5%   
Net profit margin %-55.8129.8 -43.0%  
BALANCE SHEET DATA
Current assets Rs m14,3351,867 767.8%   
Current liabilities Rs m49,809591 8,425.1%   
Net working cap to sales %-494.0101.6 -486.0%  
Current ratio x0.33.2 9.1%  
Inventory Days Days40394 428.0%  
Debtors Days Days17174 232.0%  
Net fixed assets Rs m55,4321,791 3,095.2%   
Share capital Rs m268534 50.2%   
"Free" reserves Rs m13,93510,324 135.0%   
Net worth Rs m14,70110,858 135.4%   
Long term debt Rs m9,47841 23,004.5%   
Total assets Rs m73,98811,591 638.4%  
Interest coverage x-0.4260.9 -0.1%   
Debt to equity ratio x0.60 16,990.1%  
Sales to assets ratio x0.10.1 89.6%   
Return on assets %0.514.1 3.6%  
Return on equity %-27.315.0 -181.6%  
Return on capital %-6.415.2 -42.3%  
Exports to sales %25.91.5 1,675.8%   
Imports to sales %0.221.0 0.8%   
Exports (fob) Rs m1,86019 9,586.6%   
Imports (cif) Rs m12263 4.6%   
Fx inflow Rs m1,86019 9,586.6%   
Fx outflow Rs m25264 9.4%   
Net fx Rs m1,835-244 -750.7%   
CASH FLOW
From Operations Rs m1,719236 728.9%  
From Investments Rs m-3,148-224 1,405.4%  
From Financial Activity Rs m1,426-27 -5,360.9%  
Net Cashflow Rs m-3-15 23.0%  

Share Holding

Indian Promoters % 33.9 64.0 53.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 9.9 9.7 102.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 26.1 150.6%  
Shareholders   21,482 54,701 39.3%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 495 Points, Jet Airways in Focus and Other Top Stocks in Action Today(Pre-Open)

On Monday, share markets in India opened on a negative note and ended the day deep in red after a volatile day of trading.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - BIOCON COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS